Safety and Biodistribution Profile of Placental-derived Mesenchymal Stromal Cells (PLX-PAD) Following Intramuscular Delivery
Authors:
Open Access
- 28 May 2009
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 37 (5) , 606-616
Abstract
The administration of mesenchymal stromal cells (MSCs) provides an exciting emerging therapeutic modality for the treatment of peripheral arterial disease, a condition that is associated with critical limb ischemia as its end stage. Placental-derived MSCs, termed PLX-PAD cells, are stable adhesive stromal cells isolated from full-term human placentae, cultured on carriers, and expanded in a bioreactor called the PluriX. These cells can be expanded in vitro without phenotypic or karyotypic changes. We studied the safety and biodistribution properties of PLX-PAD cells following intramuscular administration in NOD/SCID mice. No significant clinical signs, hematological and biochemical parameters, or major pathological changes were found in PLX-PAD-treated animals in comparison to vehicle controls. Several animals in the control and PLX-PAD-treated groups developed thymic malignant lymphoma, first seen after one month, as expected in this mouse strain. In addition, both groups developed spontaneous mesenteric vessel inflammation. Real-time quantitative polymerase chain reaction (RT-qPCR) demonstrated that distribution of PLX-PAD cells was confined to the injection site. Placental-derived MSCs remained in this site with gradual decrease in concentration during a three-month period. In view of these data, we conclude that the administration of PLX-PAD cells is not associated with any adverse effects in NOD/SCID mice.Keywords
This publication has 22 references indexed in Scilit:
- Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?Journal of Translational Medicine, 2008
- Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and AngiogenesisStem Cells, 2007
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- Unblinded Pilot Study of Autologous Transplantation of Bone Marrow Mononuclear Cells in Patients With Thromboangiitis ObliteransCirculation, 2006
- Critical Limb Ischemia and Stem Cell ResearchCirculation, 2006
- Diagnostic Criteria and Treatment of Buerger’s Disease: A ReviewThe International Journal of Lower Extremity Wounds, 2006
- Bone Marrow–Derived Cells for Enhancing Collateral DevelopmentCirculation Research, 2004
- Evidence for Fusion Between Cardiac and Skeletal Muscle CellsCirculation Research, 2004
- Angiogenesis by Implantation of Peripheral Blood Mononuclear Cells and Platelets Into Ischemic LimbsCirculation, 2002
- Changing potency by spontaneous fusionNature, 2002